Fig. 3From: The papilla as a biomarker in the molecular era of bladder oncologyPapillary urothelial lesion immunostained for phosS6 (Ser 235/236), 40x. This protein serves as a surrogate for mTOR activation. Its expression is shown in superficial well differentiated cells of a papillary neoplastic structureBack to article page